Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer
Go back to Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 29.66 +0.27 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.39 | 52 Week High | $42.49 | |||
| Open | $29.57 | 52 Week Low | $16.64 | |||
| Day High | $29.74 | P/E | N/A | |||
| Day Low | $29.10 | EPS | $-0.42 | |||
| Volume | 216,143 | |||||

